COVID-19

Investigators at Mount Sinai report that ocular cells may be infected directly by the virus, with the limbus especially susceptible.

According to investigators, understanding the ocular manifestations in patients with COVID-19 could ultimately help with the diagnosis and prevent transmission.

New operating procedures ensure eye clinics can operate safely amid virus.

A residency applicant shares his perspective on the pandemic’s impact.

Patients are serious about procedure and ready to move forward.

In an update, the CDC noted that the chances of an individual contracting COVID-19 from surface transmission is low.

Minimizing clinic visits, maximizing use of imaging modalities are key.

Cynthia Matossian, MD, FACS, ABES, explores the tie between mask wear and dry eye, causes behind a growing number of MGD cases, and offers mask safety tips for patient treatment.

Researchers at the Royal College of Ophthalmologists offer guidance on the impact of treatment delays in crosslinking (CXL) amid COVID-19 on patients with keratoconus.

Patients who are at an increased risk for vision loss from lapses in care have frequently expressed concerns about the impact of the pandemic on their ability to receive timely care.

The Lighthouse Guild is raising public awareness about the visually impaired, a group that has been passed over for early access to vaccinations.

Investigators at Rokote Laboratories Finland Ltd. say they selected the nasal route of delivery because the virus is transmitted through the airways, and they claim that nasal administration may induce a wider immune response than intramuscular administration.

Investigators suggest that SARS-CoV-2 may diffuse from the ocular surfaces to the patient’s body, and use of a conjunctival swab may be another method of diagnosing the virus.

Visits, elective procedures decreased as physicians responded to COVID-19 guidelines.

Physicians step-up in emergency departments during COVID-19 surge.

According to a survey by the Larry A. Green Center, in collaboration with the Primary Care Collaborative (PCC) and 3rd Conversation, primary care offers assets, including experience and relationships with patients.

Dealing with the COVID-19 virus affects everything to some degree, and investigators have found that mask wear can impact the accuracy of visual field tests.

Treatment of patients with COVID-19 should include ophthalmic considerations.

Organization works to ensure clinical care and access for high-risk patients.

The American Medical Association, American Hospital Association, American Nurses Association issued a sobering reality check as COVID-19 deaths in the United States passed the grim 500,000 milestone.

Arsham Sheybani, MD, offers insight on how his glaucoma patient management protocols have altered and the shift in subconjunctival surgery in light of the pandemic.

According to a study, ocular nodules have been found in the posterior pole and outside of the macular region in COVID-19 patients.

Biophytis will begin recruiting patients in France and Belgium for the second part of the COVA Study analyzing its leading drug candidate as a potential treatment for acute respiratory failure linked to COVID-19.

Vaccination offers hope ... if we only take the chance.

Calling all physicians — take this survey and let us know your thoughts on the COVID-19 vaccine.

Rapid test allows healthcare professionals to make fast decisions at the point of care.

Results of a survey among ophthalmologists indicate that patients are receiving fewer examinations — with worsening glaucoma, says S. Fabian Lerner, MD, speaking at the Glaucoma 360 New Horizons Forum.

According to investigators, a lack of definitive knowledge about the presence of SARS-CoV-2 in corneal tissues has resulted in the recommendation to avoid using corneal tissue for transplantation when the tissue was obtained from donors with COVID-19 that had been confirmed or those who were exposed to COVID-19.

Organization shines spotlight on frontline heroes during ongoing COVID-19 battle.

Ocular symptoms in COVID-19 patients may be more common than previously thought — with sore eyes a significant sign of disease.